Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa versus mifepristone for adenomyosis
ChiCTR2000031698Phase 4Recruiting
- Sponsor
- Women's Hospital, School of Medicine, Zhejiang University
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gonadotropin-releasing hormone agonist and mifepristone in adenomyosis (2 arms), sponsored by Women's Hospital, School of Medicine, Zhejiang University. Primary endpoints: Pain score, Change of menstrual volume and 6 more. Started Apr 2020; status: recruiting.
02
Drugs
gonadotropin-releasing hormone agonistmifepristone
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ChiCTR2000031698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031698.